Joshua Labaer

Scientific Advisor at INanoBio

Dr. Joshua LaBaer is the Director of Virginia Piper center for personalized diagnostics at the Biodesign Institute ASU, home to DNASU plasmid repository and the Sequencing Core. He is a medical oncologist, cancer researcher and nation’s leading proteomics expert. Dr. LaBaer was previously director of the Harvard Institute of Proteomics (HIP), he is founding member and serving president of US HUPO (Human Proteome Organization). He is the principal inventor of NAPPA protein microarray technologies. Dr. LaBaer is a former member of the National Cancer Institute (NCI) Board of Scientific Advisors, and currently serves as chair of NCI’s Early Detection Research Network.


Org chart

This person is not in the org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


INanoBio

INanoBio’s mission is to develop high-accuracy early-stage disease diagnostics using transformative nano-biotechnology platforms and machine learning.


Industries

Employees

11-50

Links